Ashwaq Hermes

462 total citations
8 papers, 359 citations indexed

About

Ashwaq Hermes is a scholar working on Infectious Diseases, Emergency Medicine and Virology. According to data from OpenAlex, Ashwaq Hermes has authored 8 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 5 papers in Emergency Medicine and 3 papers in Virology. Recurrent topics in Ashwaq Hermes's work include HIV/AIDS Research and Interventions (5 papers), HIV/AIDS drug development and treatment (5 papers) and HIV-related health complications and treatments (5 papers). Ashwaq Hermes is often cited by papers focused on HIV/AIDS Research and Interventions (5 papers), HIV/AIDS drug development and treatment (5 papers) and HIV-related health complications and treatments (5 papers). Ashwaq Hermes collaborates with scholars based in United States and Canada. Ashwaq Hermes's co-authors include Franck Rousseau, Elsa Mondou, Ralph DeMasi, Joseph Quinn, Michael Fath, John Bartlett, Marisol Martínez, Ronald D’Amico, Angela M. Nilius and Courtney V. Fletcher and has published in prestigious journals such as Clinical Infectious Diseases, AIDS and The Journal of Clinical Pharmacology.

In The Last Decade

Ashwaq Hermes

8 papers receiving 349 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ashwaq Hermes United States 7 277 174 80 58 52 8 359
Selly Ba Senegal 11 169 0.6× 118 0.7× 43 0.5× 65 1.1× 19 0.4× 17 276
Boaz Oyaro Kenya 11 140 0.5× 84 0.5× 28 0.3× 62 1.1× 42 0.8× 20 274
Marisol Martínez United States 7 151 0.5× 35 0.2× 52 0.7× 107 1.8× 45 0.9× 20 251
Sonya Davey United States 6 178 0.6× 58 0.3× 53 0.7× 49 0.8× 66 1.3× 12 289
Natascia Sala Italy 9 316 1.1× 250 1.4× 215 2.7× 112 1.9× 22 0.4× 12 480
Nicola Mackie United Kingdom 13 369 1.3× 275 1.6× 99 1.2× 98 1.7× 15 0.3× 31 448
John Begley United States 7 311 1.1× 204 1.2× 41 0.5× 65 1.1× 29 0.6× 11 402
Maria Pia De Pasquale Italy 9 284 1.0× 231 1.3× 28 0.3× 66 1.1× 14 0.3× 12 343
Judith Mabuta Botswana 6 226 0.8× 63 0.4× 85 1.1× 56 1.0× 94 1.8× 16 376
Fatima Kakkar Canada 9 172 0.6× 40 0.2× 59 0.7× 87 1.5× 31 0.6× 27 273

Countries citing papers authored by Ashwaq Hermes

Since Specialization
Citations

This map shows the geographic impact of Ashwaq Hermes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashwaq Hermes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashwaq Hermes more than expected).

Fields of papers citing papers by Ashwaq Hermes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashwaq Hermes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashwaq Hermes. The network helps show where Ashwaq Hermes may publish in the future.

Co-authorship network of co-authors of Ashwaq Hermes

This figure shows the co-authorship network connecting the top 25 collaborators of Ashwaq Hermes. A scholar is included among the top collaborators of Ashwaq Hermes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashwaq Hermes. Ashwaq Hermes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Agarwal, Sanjay K., et al.. (2021). Real-world characteristics of women with endometriosis-related pain entering a multidisciplinary endometriosis program. BMC Women s Health. 21(1). 19–19. 17 indexed citations
2.
Martínez, María Ángeles Gómez, et al.. (2013). Systematic review of the safety and efficacy of Lopinavir/ritonavir-based antiretroviral therapy in pregnant women. Journal of the International AIDS Society. 16(Suppl 1). 1 indexed citations
3.
Martínez, Marisol, et al.. (2013). Safety and efficacy of lopinavir/ritonavir during pregnancy: a systematic review.. PubMed. 15(1). 38–48. 40 indexed citations
4.
Hermes, Ashwaq, K. Squires, Linda Fredrick, et al.. (2012). Meta-Analysis of the Safety, Tolerability, and Efficacy of Lopinavir/Ritonavir-Containing Antiretroviral Therapy in HIV-1–Infected Women. HIV Clinical Trials. 13(6). 308–323. 9 indexed citations
5.
Currier, Judith S., et al.. (2011). Sex Differences in Lopinavir and Ritonavir Pharmacokinetics Among HIV-Infected Women and Men. The Journal of Clinical Pharmacology. 51(12). 1665–1673. 27 indexed citations
6.
Stek, Alice, Brookie M. Best, Chengcheng Hu, et al.. (2009). Lopinavir protein binding in HIV‐1‐infected pregnant women. HIV Medicine. 11(4). 232–238. 39 indexed citations
7.
Letendre, Scott, Ashwaq Hermes, Janis Durelle, et al.. (2007). Lopinavir with Ritonavir Reduces the HIV RNA Level in Cerebrospinal Fluid. Clinical Infectious Diseases. 45(11). 1511–1517. 37 indexed citations
8.
Bartlett, John, Michael Fath, Ralph DeMasi, et al.. (2006). An updated systematic overview of triple combination therapy in antiretroviral-naive HIV-infected adults. AIDS. 20(16). 2051–2064. 189 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026